ChemicalBook > CAS DataBase List > Manelimab

Manelimab

Product Name
Manelimab
CAS No.
2168561-26-8
Chemical Name
Manelimab
Synonyms
Manelimab;Manelimab (anti-PD-L1);Research Grade Manelimab;Research Grade Manelimab(DHJ70107)
CBNumber
CB78081176
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Manelimab Chemical Properties,Usage,Production

Uses

Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1)[1].

References

[1] Aleksey Vladimirovich KONONOV, et al. Immunocytokine for activating human il-10ra receptor and use thereof. WO2022/124950 Al.

Manelimab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Manelimab Suppliers

China 12 Global 12
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Cell Sciences
Tel
9785721070
Email
info@cellsciences.com
Country
China
ProdList
6308
Advantage
58

2168561-26-8, ManelimabRelated Search:

Research Grade Cantuzumab (DHD14203) Lexatumumab Anetumab Ravtansine Caplacizumab Besilesomab Brodalumab Rosopatamab Panobacumab Sonelokimab Tanezumab

  • Manelimab
  • Research Grade Manelimab(DHJ70107)
  • Research Grade Manelimab
  • Manelimab (anti-PD-L1)
  • 2168561-26-8